pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 5·1 min read
save

Swiss manufacturing, biotech industry so far unfazed by geopolitics

BASEL, Switzerland — Pharma manufacturing in Switzerland appears to be unperturbed by the threat of tariffs, but it might take several years before the impact of companies moving production to the US becomes clear. According to ...

May 5, 2026·read at Endpoints ↗

Swiss Biotech Day 2026 (Supplied) May 5, 2026 10:55 AM EDT PharmaManufacturing Swiss man­u­fac­tur­ing, biotech in­dus­try so far un­fazed by geopol­i­tics Anna Brown News Reporter BASEL, Switzer­land — Phar­ma man­u­fac­tur­ing in Switzer­land ap­pears to be un­per­turbed by the threat of tar­iffs, but it might take sev­er­al years be­fore the im­pact of … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
86 words · retrieved May 5
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 3h agoNovartis' drug delivery deal with Alteogen; More worker cuts at CellaresEndpoints
  • 3h agoPfizer shares ADC rights with Medicus; RevMed updates lung cancer dataEndpoints
  • 4h agoAbbVie claims Phase 3 win for multiple myeloma drug etentamigEndpoints
  • 5h agoHealth tech investors are looking at bigger betsEndpoints
  • 7h agoSummit, Akeso say ivonescimab clears OS bar in Phase 3 lung cancer trialEndpoints